Susquehanna International Group’s NLS Pharmaceutics Warrant NLSPW Stock Holding History

Susquehanna International Group’s Portfolio NLSPW Stock Details NLSPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-45,830	Closed	-$731	–	13176
2025 Q3	$731	Buy	45,830 +29,497	+181%	+$469	﹤0.01%	12211
2025 Q2	$309	Buy	+16,333	New	+$214	﹤0.01%	12533
2024 Q3	–	Sell	-12,221	Closed	-$368	–	12680
2024 Q2	$368	Sell	12,221 -327	-3%	-$11	﹤0.01%	11890
2024 Q1	$612	Buy	+12,548	New	+$719	﹤0.01%	12026

Susquehanna International Group's NLSPW Position: Q4 2025 in Review

Susquehanna International Group sold out of NLS Pharmaceutics Warrant (NLSPW) in Q4 2025, closing a stake of 45,830 shares — an estimated $731 sold.

Susquehanna International Group first reported a position in NLSPW in Q1 2024 and held it in 4 quarters. The position peaked at $731 in Q3 2025. 0 funds tracked by Wall St. Rank hold NLSPW as of Q4 2025.

Susquehanna International Group reported no remaining NLS Pharmaceutics Warrant position as of Q4 2025 after selling out during the quarter.
Susquehanna International Group sold 45,830 NLS Pharmaceutics Warrant shares in Q4 2025, an estimated $731.
Susquehanna International Group first reported a position in NLS Pharmaceutics Warrant in Q1 2024 and held it in 4 quarters.
Susquehanna International Group's NLS Pharmaceutics Warrant position peaked at $731 in Q3 2025.
0 funds tracked by Wall St. Rank held NLS Pharmaceutics Warrant as of Q4 2025.

Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.